GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $63.87 $84.89 Wednesday, 17th Apr 2024 ITCI stock ended at $76.69. This is 3.95% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 8.82% from a day low at $76.50 to a day high of $83.25.
90 days $62.78 $84.89
52 weeks $45.50 $84.89

Historical Intra-Cellular Therapies Inc. prices

Date Open High Low Close Volume
2024-04-17 $79.00 $83.25 $76.50 $76.69 2 524 522
2024-04-16 $75.29 $84.89 $75.00 $79.84 7 317 021
2024-04-15 $65.71 $66.05 $64.16 $64.76 492 999
2024-04-12 $67.63 $67.89 $64.84 $65.88 573 953
2024-04-11 $67.89 $68.68 $66.53 $67.97 430 671
2024-04-10 $67.12 $67.57 $66.53 $67.28 541 271
2024-04-09 $68.07 $68.97 $67.91 $68.62 472 577
2024-04-08 $68.74 $68.91 $67.33 $67.70 269 778
2024-04-05 $67.29 $69.49 $67.05 $68.44 628 257
2024-04-04 $68.49 $69.33 $66.61 $67.21 635 169
2024-04-03 $66.28 $68.73 $65.99 $67.32 527 358
2024-04-02 $66.94 $66.95 $65.93 $66.67 481 424
2024-04-01 $69.20 $69.36 $67.73 $68.27 356 025
2024-03-28 $69.78 $70.00 $68.14 $69.20 862 282
2024-03-27 $67.94 $69.75 $67.50 $69.72 401 298
2024-03-26 $68.88 $69.27 $67.13 $67.33 282 257
2024-03-25 $69.59 $70.07 $67.82 $67.97 625 045
2024-03-22 $68.74 $69.90 $68.74 $69.02 715 400
2024-03-21 $67.78 $69.27 $67.38 $68.38 598 028
2024-03-20 $65.50 $67.41 $64.95 $67.21 960 583
2024-03-19 $63.91 $66.67 $63.87 $65.45 496 210
2024-03-18 $64.97 $65.98 $64.75 $65.37 488 590
2024-03-15 $64.46 $65.09 $63.92 $64.78 1 007 907
2024-03-14 $64.96 $65.10 $63.30 $64.57 609 960
2024-03-13 $64.26 $65.74 $64.04 $65.21 471 192
Click to get the best stock tips daily for free!

About Intra-Cellular Therapies Inc.

Intra-Cellular Therapies. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as ... ITCI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT